Svar Life Science

What Svar Life Science does

Svar Life Science is a private Swedish life science company that invents, develops, and applies analytical technologies for drug development and clinical diagnostics. Founded in 1992 and headquartered in Malmö, the company operates an assay product business (iLite cell-based reporter gene assays, Wieslab complement ELISAs, CCP assays, and the AAV Immunogenicity Suite), a contract research organization offering GLP-compliant bioanalysis, biomarker discovery, and GMP QC testing, and an ISO15189-accredited diagnostic laboratory (Wieslab Diagnostic Services) that processes autoimmune and neurological send-out tests. Underlying the reagent offering is the proprietary iLite platform, built on genetically engineered HEK293 cells with dual Firefly/Renilla luciferase readouts, which in its second-generation form delivers assay-ready, 5-hour workflows versus the prior 18-hour format. The company also offers custom cell line development, master cell bank manufacturing, Tissue-Based Assays for neuronal autoantibodies, SIMOA-based ultra-sensitive biomarker quantification (e.g., GFAP), and—via partnerships—LC-MS/MS bioanalysis (Lablytica) and Olink Proximity Extension Assay proteomics (first Nordic-certified CRO).

The company serves three primary customer segments: pharmaceutical and biotechnology drug developers (potency, safety, immunogenicity, complement, and gene/cell therapy evaluation work), clinical diagnostics users (hospitals, labs, and physicians using Wieslab Diagnostic Services for autoimmune and neurological testing), and academic/research institutions (assays and custom development). Revenue mechanics combine one-time assay product sales, professional-services CRO contracts, and recurring diagnostic testing send-outs. The GTM model blends direct enterprise field sales for CRO engagements and large pharma accounts with a global distributor network for catalog assay products, and an inbound quote-based digital motion through the company website; pricing is not publicly disclosed. The US subsidiary (Svar Life Science Inc, Amherst, NH) supports North American enterprise customers, while headquarters and the diagnostic lab remain in Malmö.

Name

Svar Life Science

Legal name

Svar Life Science

Website

https://svarlifescience.com

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

51–100 employees

Short description

Svar Life Science develops proprietary cell-based assays (iLite), complement pathway tests (Wieslab), and AAV immunogenicity suites for pharmaceutical and biotech drug developers and clinical diagnostics laboratories. Headquartered in Malmö, Sweden, it sells assay products, CRO services, and ISO15189-accredited diagnostic testing globally.

Ownership category

akta.pro rank

Product category

Life Science Analytical Products and Bioanalytical Services

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Testing Laboratories and Services (54138)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)

akta.pro secondary industries

Cell-Based & Potency Assays (Bioassays) (HLAGADAH), Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC), Analytical Development & QC Testing (Release/Stability/Potency) (HLAGAGAF)

Keywords

• Cell-based bioassays
• Complement system assays
• Gene therapy immunogenicity
• CRO bioanalytical services
• Autoimmune diagnostics

Headquarters

HQ city

Malmö

HQ country

Sweden

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales

Revenue model

1. Diagnostic Testing Services: Recurring revenue from diagnostic testing services provided by the Wieslab Diagnostic Services laboratory, including autoimmune and neurological disorder testing, and ongoing therapeutic drug monitoring.
2. Assay Product Sales: Sale of assay products including iLite® assay-ready cells, complement ELISAs, CCP assays, and ganglioside/MAG antibody kits to research, clinical, and commercial laboratory customers worldwide.
3. CRO Services: CRO Services including bioanalytical services, biomarker discovery, GMP QC testing, and custom cell development provided to pharmaceutical and biotech companies on a contract basis.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Core offering

Svar Life Science invents, develops, manufactures, and sells proprietary analytical assay products (cell-based iLite® reporter gene assays, Wieslab® complement ELISAs, CCP antibody kits, and AAV immunogenicity assays) used by pharmaceutical, biotech, clinical, and academic laboratories. The company also delivers contract research services including GLP-compliant bioanalysis, biomarker discovery, and GMP QC testing, and operates an ISO 15189-accredited diagnostic laboratory for autoimmune and neurological disorder testing under the Wieslab brand.

Differentiator

Problem solved

Functional benefit

Brands

• Wieslab: Diagnostic services brand specializing in autoimmune diagnostics with ISO 15189-certified laboratory services.
• iLite
• AAV Immunogenicity Suite

Products and services

• iLite® Cell-Based Luciferase Reporter Assays Proprietary cell-based bioassays built on the iLite® reporter gene technology platform using genetically engineered HEK293 cells with dual Firefly/Renilla luciferase readouts. Used by pharmaceutical and biotech companies for bioactivity, ADCC, ADCP, CDC, and T-cell activation assays in drug development.
• Wieslab® Complement System Assays Complete portfolio of ELISA-based functional and biomarker assays covering the classical, lectin, and alternative complement pathways, including C3, C4, C4d, C5a, Factor P, and TCC (Terminal Complement Complex) kits. Available for over 20 years and used in research, clinical, and commercial laboratory settings.
• AAV Complement Activation Assay First-of-its-kind assay on the market for detecting complement activation immune responses in AAV gene therapy programs. Completes the AAV Immunogenicity Suite trifecta (NAb + TAb + Complement Activation), used by gene therapy developers to assess vector immunogenicity.
• AAV Neutralizing Antibody (NAb) Assays Cell-based iLite® assays for quantifying neutralizing antibodies against AAV gene therapy vectors. Used by gene therapy developers in preclinical and clinical immunogenicity assessments.
• AAV Total Antibody (TAb) Assays Assays for measuring total binding antibodies against AAV vectors in gene therapy drug development programs. Part of the comprehensive AAV Immunogenicity Suite alongside NAb and Complement Activation assays.
• CCP Antibody Assays Solutions for detecting and semi-quantitating IgG antibodies against cyclic citrullinated peptide (CCP), used in the diagnosis of rheumatoid arthritis in clinical and commercial laboratory settings.
• ADCC & ADCP Bioassays Cell-based iLite® bioassays for measuring antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP), used in potency characterization for biologics.
• CDC Bioassays Cell-based iLite® bioassays for measuring complement-dependent cytotoxicity (CDC), used in potency characterization for biologics and biosimilars.
• T-Cell Activation Bioassays Cell-based iLite® bioassays for measuring T-cell activation in immunogenicity and mechanism-of-action studies for biologic drug development.
• CRO Services Contract research services including bioanalytical services, biomarker discovery, and GMP QC testing for pharmaceutical and biotech customers. Delivered through dedicated service pages for bioanalytical, biomarker discovery, and QC testing workstreams.
• Wieslab Diagnostic Services ISO 15189-certified specialty diagnostic laboratory offering autoimmune and neurological disease testing (rheumatoid arthritis, SLE, vasculitis, autoimmune encephalitis, NMOSD, MOGAD, Guillain-Barré syndrome, Alzheimer's disease biomarkers) plus therapeutic drug monitoring. Samples are received from hospitals, clinics, and physicians worldwide.
• iLite® Custom Cell Line Development Custom development service to engineer iLite® reporter gene cell lines tailored to customer-specific targets and assay requirements, used by pharmaceutical and academic researchers requiring bespoke cell-based assays.
• Master Cell Bank Development and Assay Ready Cell Service Cell manufacturing services including Master Cell Bank Development and Assay Ready Cell Service, supporting customer cell production needs with reliable, innovative, tailored manufacturing capabilities.
• iLite® C3a Assay Ready Cells Cell-based bioassay for studying the complement system component C3a, using iLite® technology with reporter gene readouts. Targeted at researchers studying complement activation pathways.
• GFAP in Serum Diagnostic Test Diagnostic test for Glial Fibrillary Acidic Protein (GFAP) in serum using the SIMOA platform, used to provide biomarker information for traumatic brain injury, stroke, and certain neurodegenerative and neuroinflammatory conditions.

Quantifiable outcome

• Second-generation iLite® cells reduce assay time from 18 hours to 5 hours while maintaining comparable dynamic range, plate homogeneity, and day-to-day accuracy
• +2 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Two partnerships are on record, tiered core.

• Lablytica Life SciencecoreStrategic or Co-development Partner · 30 March 2026Svar Life Science and Lablytica Life Science announced a strategic partnership for advanced LC-MS/MS technology. The partnership enables Svar to offer LC-MS/MS-based bioanalytical services as part of their CRO service portfolio, enhancing capabilities in small molecule and protein quantification for pharmaceutical development.
• Olink ProteomicscoreTechnology or IntegrationSvar became the first CRO certified for Olink Proteomics Services in the Nordics. This certification enables Svar to offer Olink's targeted proteomics platform (based on Proximity Extension Assay technology) as part of their biomarker discovery services, providing high-multiplex protein biomarker analysis capabilities to pharmaceutical customers in the Nordic region.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Bio-Techne: Bio-Techne is a major life science reagent and assay manufacturer with deep exposure to immunoassays, biomarkers, and cell-based kits. It overlaps with Svar's assay product portfolio but operates at much greater scale across broader research and clinical segments.
• Abcam: Abcam is a large research reagent supplier with extensive antibody, ELISA, and assay kit catalogs. While it is broader and less specialized, it competes with Svar's assay kits in autoimmune and complement research markets.
• Binding Site (Thermo Fisher): The Binding Site, part of Thermo Fisher, is a specialty diagnostics company focused on immune system disorders including autoantibody and protein diagnostics. It competes with Wieslab Diagnostic Services in autoimmune and protein diagnostics testing.
• Charles River Laboratories: Charles River is a major CRO providing bioanalytical, safety, and cell-based assay services to biopharma. Its bioanalytical and biologics safety assessment services overlap with Svar's GMP QC and GLP bioanalytical CRO offerings.
• QuidelOrtho: QuidelOrtho is a diagnostic company offering specialty autoimmune and infectious disease testing. It competes with Svar's Wieslab Diagnostic Services in clinical autoimmunity and complement diagnostics, though at much larger scale.
• Eurofins Scientific: Eurofins is a global contract testing services giant offering bioanalytical, biomarker, and pharma product testing. It competes with Svar's CRO services and Wieslab diagnostic services, but at vastly greater scale and geographic reach.

Direct peers

• GenScript: GenScript provides cell-based assay development, custom cell line engineering, and bioanalytical services to biopharma. Its custom cell line and assay development capabilities closely mirror Svar's iLite custom cell development offering.
• Promega: Promega develops cell-based reporter gene assays, luminescent detection chemistries, and bioanalytical tools used in drug development. Its luciferase-based assay systems and potency testing reagents directly parallel Svar's iLite platform and bioassay services.
• Complement Technology Inc. Complement Technology Inc. is a specialized supplier of complement reagents, proteins, and assay kits for complement system research. It is a focused competitor in the complement assay niche that Svar's Wieslab brand has built over 20 years.
• Hycult Biotech: Hycult Biotech specializes in immunology and complement-focused research reagents and assay kits, including complement ELISAs and functional assays. Its complement assay portfolio directly competes with Svar's Wieslab line.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/svarlifescience
• LinkedInlinkedin.com/company/svarlifescience-ab
• Instagraminstagram.com/svarlifescienceab

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Svar Life Science